The global CAR T-cell therapy market is experiencing explosive growth, driven by growing demand for innovative cancer treatments. This treatment involves modifying a patient's own immune cells to attack cancer cells, offering encouraging results in the treatment of numerous blood cancers. Key factors fueling market expansion include advancements in